Crescent Biopharma Inc Share Price (NASDAQ: CBIO)

Crescent Biopharma Inc Stock Performance

as on October 4, 2025 at 1:27 am IST

Day's Low
Day's High
$11.53
Day's Price Range
$12.19
$11.71
1.54%
Downside
4.10%
Upside
52 Week's Low
52 Week's High
$10.83
52-Week Price Range
$21.4
$11.71
7.51%
Downside
82.75%
Upside

Crescent Biopharma Inc share price movements today

Previous Close: $12.03
Open: $12.19
Volume: 294.2K
Day's Low - High: $11.53 - $12.19
52 Week Low - High: $10.83 - $21.4

Crescent Biopharma Inc Historical Returns

1 Month Return: -14.39 %
3 Month Return: -26.24 %
1 Year Return: 0 %
3 Year Return: + 50.17 %
5 Year Return: -82.83 %

Crescent Biopharma Inc Stock Fundamentals & Key Indicators

Check Crescent Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$292.5M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

62831200.00%

Crescent Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Crescent Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Crescent Biopharma Inc	NA	$292.5M	-82.83%	NA	0.00%
Beone Medicines Ltd	NA	$40.5B	NA	NA	-3.89%
Alnylam Pharmaceuticals, Inc.	BUY	$60.4B	236.34%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$104.8B	54.64%	29.06	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$63.6B	6.23%	15.13	31.37%

Stock Returns calculator for Crescent Biopharma Inc Stock including INR - Dollar returns

The Crescent Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Crescent Biopharma Inc investment value today

Current value as on today

₹1,59,043

Returns

₹59,043

(+59.04%)

Returns from Crescent Biopharma Inc Stock

₹50,128 (+50.13%)

Dollar Returns*

₹8,914 (+8.91%)

Crescent Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	0	-	-	-	25	25	105	22
Gross Profit	-	-	-1	-	-	-	24	24	102	21
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	51	-4	-40	0	-2	-1	7	5	32	5
Net Profit Margin	0.00%	0.00%	5094.96%	0.00%	0.00%	0.00%	29.86%	19.63%	30.57%	25.10%

Crescent Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024
Total Revenue	0	1	0	1	0	-	20	7	0	105
Gross Profit	0	1	0	1	0	-43	11	0	0	101
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-32	-14	-16	-21	-30	-52	-55	-87	-8	28
Net Profit Margin	-11862.91%	-843.54%	-4246.87%	-2117.98%	-500916.67%	0.00%	-265.14%	-1197.79%	-1038.04%	26.98%

Global Institutional Holdings in Crescent Biopharma Inc

Funds	Holdings
Raymond James & Associates	0%
Cutler Group LP	0%
Vanguard Group Inc	0%
Wells Fargo & Co	0%
UBS Group AG	0%

See all

Insights on Crescent Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CBIO has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, CBIO stock has moved up by 5570.0%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 127.8% return, outperforming this stock by 70.5%

About Crescent Biopharma Inc

Crescent Biopharma, Inc. is a biotechnology company. The Company is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Company’s lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.

Organisation	Crescent Biopharma Inc
Headquarters	300 Fifth Avenue, Waltham, MA, United States, 02451
CEO	Mr. Joshua T. Brumm
E-voting on shares	Click here to vote

Key Management of Crescent Biopharma Inc

Name	Title
Mr. Christopher Doughty	Chief Business Officer
Dr. Ellie Im M.D.	Chief Medical Officer
Mr. Richard William Scalzo M.B.A.	Chief Financial Officer
Dr. Jan Pinkas Ph.D.	Chief Scientific Officer
Mr. Ryan Lynch	Senior VP of Finance, Treasurer & Chief Accounting Officer
Ms. Barbara H. Bispham J.D.	General Counsel & Corporate Secretary
Ms. Amy Reilly	Chief Communications Officer
Dr. Wenjie Cheng Ph.D.	Senior Vice President of Technical Operations
Mr. Joshua T. Brumm	CEO & Director
Dr. Jonathan McNeill M.D.	President & COO

FAQs

What is Crescent Biopharma Inc share price today?

Crescent Biopharma Inc share price today is $11.71 as on October 4, 2025 at 1:27 am IST at the close of the market. Crescent Biopharma Inc share today touched a day high of $12.19 and a low of $11.53.

What is the 52 week high and 52 week low for Crescent Biopharma Inc share?

Crescent Biopharma Inc share touched a 52 week high of $21.4 on June 25, 2025 and a 52 week low of $10.83 on August 8, 2025. Crescent Biopharma Inc stock price today i.e. October 4, 2025 at 1:27 am IST is closed at $11.71,which is 45.28% down from its 52 week high and 8.13% up from its 52 week low.

What is Crescent Biopharma Inc's market capitalisation today?

Crescent Biopharma Inc market capitalisation is $0.00T as on October 4, 2025 at 1:27 am IST.

How to invest in Crescent Biopharma Inc Stock (CBIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Crescent Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crescent Biopharma Inc Shares that will get you 0.1281 shares as per Crescent Biopharma Inc share price of $11.71 per share as on October 4, 2025 at 1:27 am IST.

What is the minimum amount required to buy Crescent Biopharma Inc Stock (CBIO) from India?

Indian investors can start investing in Crescent Biopharma Inc (CBIO) shares with as little as ₹88.775 or $1 (as of October 5, 2025 at 11:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.75 in Crescent Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on October 5, 2025 at 11:39 pm IST). Based on Crescent Biopharma Inc share’s latest price of $11.71 as on October 4, 2025 at 1:27 am IST, you will get 0.8540 shares of Crescent Biopharma Inc. Learn more about fractional shares .

What are the returns that Crescent Biopharma Inc has given to Indian investors in the last 5 years?

Crescent Biopharma Inc stock has given -82.83% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?